• OPEN AN ACCOUNT
Indian Indices
Sensex
74,708.79 -150.20
( -0.20%)
Global Indices
Nasdaq
52,073.35 369.71
(0.72%)
Dow Jones
7,785.28 113.78
(1.48%)
Hang Seng
65,040.24 903.99
(1.41%)
Nikkei 225
10,737.46 78.33
(0.73%)
Forex
USD-INR
95.99 0.12
(0.12%)
EUR-INR
110.24 0.24
(0.22%)
GBP-INR
128.54 0.36
(0.28%)
JPY-INR
0.61 0.00
(-0.53%)

EQUITY - MARKET SCREENER

Satani Bearings Ltd
Industry :  Trading
BSE Code
ISIN Demat
Book Value()
505703
INE498D01012
8.97
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
N.A
0
581.6
EPS(TTM)
Face Value()
Div & Yield %
0.05
10
0
 

Balaxi Pharmaceuticals consolidated net profit declines 92.94% in the March 2026 quarter
May 29,2026
Net profit of Balaxi Pharmaceuticals declined 92.94% to Rs 0.61 crore in the quarter ended March 2026 as against Rs 8.64 crore during the previous quarter ended March 2025. Sales declined 7.29% to Rs 70.71 crore in the quarter ended March 2026 as against Rs 76.27 crore during the previous quarter ended March 2025.

For the full year,net profit declined 94.34% to Rs 1.42 crore in the year ended March 2026 as against Rs 25.07 crore during the previous year ended March 2025. Sales declined 7.65% to Rs 270.17 crore in the year ended March 2026 as against Rs 292.56 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales70.7176.27 -7 270.17292.56 -8
OPM %0.1716.45 -3.1612.72 -
PBDT2.0510.12 -80 7.4530.56 -76
PBT1.409.66 -86 5.2928.67 -82
NP0.618.64 -93 1.4225.07 -94